Gene Page:FAM46C
概括?
基因 | 54855 |
象征 | FAM46C |
Synonyms | - |
Description | family with sequence similarity 46 member C |
Reference | MIM:613952|HGNC:HGNC:24712|Ensembl:ENSG00000183508|HPRD:13312|Vega:OTTHUMG00000013703 |
Gene type | protein-coding |
Map location | 1p12 |
Pascal p-value | 0.157 |
Fetal beta | 0.303 |
DMG | 2 (# studies) |
数据源中的基因
Gene set name | Method of gene set | Description | Info |
---|---|---|---|
CV:PGCnp | Genome-wide Association Study | GWAS | |
DMG:Jaffe_2016 | Genome-wide DNA methylation analysis | This dataset includes 2,104 probes/CpGs associated with SZ patients (n=108) compared to 136 controls at Bonferroni-adjusted P < 0.05. | 2 |
DMG:Montano_2016 | Genome-wide DNA methylation analysis | This dataset includes 172 replicated associations between CpGs with schizophrenia. | 2 |
GSMA_I | Genome scan meta-analysis | Psr: 0.0235 | |
GSMA_IIA | Genome scan meta-analysis (All samples) | Psr: 0.00814 |
第一节遗传学和表观遗传学注释
Differentially methylated gene
Probe | Chromosome | Position | Nearest gene | P (dis) | Beta (dis) | FDR (dis) | Study |
---|---|---|---|---|---|---|---|
CG25767870 | 1 | 118188756 | FAM46C | 2.69E-4 | 0.006 | 0.173 | DMG:Montano_2016 |
CG13482356 | 1 | 118148519 | FAM46C | 2.28E-10 | -0.022 | 5.98E-7 | DMG:Jaffe_2016 |
Section II. Transcriptome annotation
General gene expression (GTEx)
![Not available](http://www.tjghsg.com/bioinfo/SZGR/GeneImg/FAM46C_DE_GTEx.png)
Gene expression during devlopment (BrainCloud)
脚注:
A total of 269 time points ploted, with n=38 fetal samples (x=1:38). Each triangle represents one time point.
Gene expression of temporal and spatial changes (BrainSpan)
脚注:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
死神:胎儿(13 - 26所示postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
No co-expressed genes in brain regions
V.途径注释
Pathway name | Pathway size | # SZGR 2.0 genes in pathway | Info |
---|---|---|---|
HOOI ST7 TARGETS DN | 123 | 78 | 该途径中的所有SZGR 2.0基因 |
CHARAFE BREAST CANCER LUMINAL VS BASAL UP | 380 | 215 | 该途径中的所有SZGR 2.0基因 |
CHARAFE BREAST CANCER LUMINAL VS MESENCHYMAL UP | 450 | 256 | 该途径中的所有SZGR 2.0基因 |
vecchi胃癌早期DN | 367 | 220 | 该途径中的所有SZGR 2.0基因 |
ODONNELL TFRC TARGETS UP | 456 | 228 | 该途径中的所有SZGR 2.0基因 |
ODONNELL TARGETS OF MYC AND TFRC UP | 83 | 50 | 该途径中的所有SZGR 2.0基因 |
JAATINEN HEMATOPOIETIC STEM CELL DN | 226 | 132 | 该途径中的所有SZGR 2.0基因 |
RODRIGUES THYROID CARCINOMA ANAPLASTIC DN | 537 | 339 | 该途径中的所有SZGR 2.0基因 |
WONG ENDOMETRIAL CANCER LATE | 10 | 5 | 该途径中的所有SZGR 2.0基因 |
PEREZ TP53 TARGETS | 1174 | 695 | 该途径中的所有SZGR 2.0基因 |
PEREZ TP63 TARGETS | 355 | 243 | 该途径中的所有SZGR 2.0基因 |
PEREZ TP53 AND TP63 TARGETS | 205 | 145 | 该途径中的所有SZGR 2.0基因 |
LINDGREN BLADDER CANCER CLUSTER 2B | 392 | 251 | 该途径中的所有SZGR 2.0基因 |
YORDY RECIPROCAL REGULATION BY ETS1 AND SP100 DN | 87 | 48 | 该途径中的所有SZGR 2.0基因 |
MARTORIATI MDM4 TARGETS FETAL LIVER DN | 514 | 319 | 该途径中的所有SZGR 2.0基因 |
NUYTTEN NIPP1 TARGETS DN | 848 | 527 | 该途径中的所有SZGR 2.0基因 |
PASQUALUCCI LYMPHOMA BY GC STAGE UP | 283 | 177 | 该途径中的所有SZGR 2.0基因 |
BENPORATH SUZ12 TARGETS | 1038 | 678 | 该途径中的所有SZGR 2.0基因 |
MORI PLASMA CELL UP | 51 | 29 | 该途径中的所有SZGR 2.0基因 |
MATSUDA NATURAL KILLER DIFFERENTIATION | 475 | 313 | 该途径中的所有SZGR 2.0基因 |
IVANOVA HEMATOPOIESIS MATURE CELL | 293 | 160 | 该途径中的所有SZGR 2.0基因 |
MCLACHLAN DENTAL CARIES UP | 253 | 147 | 该途径中的所有SZGR 2.0基因 |
KRIGE RESPONSE TO TOSEDOSTAT 6HR DN | 911 | 527 | 该途径中的所有SZGR 2.0基因 |
KRIGE RESPONSE TO TOSEDOSTAT 24HR DN | 1011 | 592 | 该途径中的所有SZGR 2.0基因 |
ZHENG BOUND BY FOXP3 | 491 | 310 | 该途径中的所有SZGR 2.0基因 |
ZHENG FOXP3 TARGETS UP | 26 | 16 | 该途径中的所有SZGR 2.0基因 |
FOSTER TOLERANT MACROPHAGE UP | 156 | 92 | 该途径中的所有SZGR 2.0基因 |
BOYLAN MULTIPLE MYELOMA C D DN | 252 | 155 | 该途径中的所有SZGR 2.0基因 |
VANASSE BCL2 TARGETS UP | 40 | 25 | 该途径中的所有SZGR 2.0基因 |
SWEET LUNG CANCER KRAS DN | 435 | 289 | 该途径中的所有SZGR 2.0基因 |
SHEDDEN LUNG CANCER GOOD SURVIVAL A12 | 317 | 177 | 该途径中的所有SZGR 2.0基因 |
BOYLAN MULTIPLE MYELOMA PCA1 UP | 101 | 66 | 该途径中的所有SZGR 2.0基因 |
GUTIERREZ WALDENSTROEMS MACROGLOBULINEMIA 1 DN | 9 | 7 | 该途径中的所有SZGR 2.0基因 |
MARTENS TRETINOIN RESPONSE DN | 841 | 431 | 该途径中的所有SZGR 2.0基因 |
CHICAS RB1 TARGETS CONFLUENT | 567 | 365 | 该途径中的所有SZGR 2.0基因 |
Wang对GSK3抑制剂SB216763 DN的响应 | 374 | 217 | 该途径中的所有SZGR 2.0基因 |
Dutertre雌二醇反应24小时 | 324 | 193 | 该途径中的所有SZGR 2.0基因 |
PILON KLF1 TARGETS UP | 504 | 321 | 该途径中的所有SZGR 2.0基因 |
BHAT ESR1 TARGETS NOT VIA AKT1 UP | 211 | 131 | 该途径中的所有SZGR 2.0基因 |
BHAT ESR1 TARGETS VIA AKT1 UP | 281 | 183 | 该途径中的所有SZGR 2.0基因 |
PLASARI TGFB1 SIGNALING VIA NFIC 1HR UP | 33 | 25 | 该途径中的所有SZGR 2.0基因 |
HOLLEMAN ASPARAGINASE RESISTANCE B ALL UP | 26 | 15 | 该途径中的所有SZGR 2.0基因 |
HOLLEMAN ASPARAGINASE RESISTANCE ALL UP | 22 | 14 | 该途径中的所有SZGR 2.0基因 |
Section VI. microRNA annotation
miRNA family | Target position | miRNA ID | miRNA seq | ||
---|---|---|---|---|---|
UTR start | UTR end | Match method | |||
miR-141/200a | 1364 | 1371 | 1A,m8 | hsa-miR-141 | uaacacugucugugugugugaugg |
HSA-MIR-200A | UAACACUGUCUGGUAACGAUGU | ||||
miR-17-5p/20/93.mr/106/519.d | 1347 | 1354 | 1A,m8 | hsa-miR-17-5p | caaagugcuuacugcagguagu |
hsa-miR-20abrain | UAAAGUGCUUAUAGUGCAGGUAG | ||||
hsa-miR-106a | AAAAGUGCUUACAGUGCAGGUAGC | ||||
hsa-miR-106bSZ | UAAAGUGCUGACAGUGCAGAU | ||||
hsa-miR-20bSZ | CAAAGUGCUCAUAGUGCAGGUAG | ||||
HSA-MIR-519D | caaagugccucccuuuagugugu | ||||
miR-19 | 2045 | 2052 | 1A,m8 | hsa-miR-19a | UGUGCAAAUCUAUGCAAAACUGA |
hsa-miR-19b | ugugcaaauccaugcaaaacuga | ||||
miR-24 | 175 | 181 | 1A | hsa-miR-24SZ | UGGCUCAGUUCAGCAGGAACAG |
miR-26 | 712 | 718 | 1A | hsa-miR-26abrain | UUCAAGUAAUCCAGGAUAGGC |
hsa-miR-26bSZ | uucaaguaauucaggauagguu | ||||
miR-299-5p | 583 | 589 | 1A | hsa-miR-299-5p | UGGUUUACCGUCCCACAUACAU |
miR-30-5p | 3848 | 3854 | m8 | HSA-MIR-30A-5P | UGUAAACAUCCUCGACUGGAAG |
hsa-miR-30cbrain | uguaaacauccuacucucucucucagc | ||||
hsa-miR-30dSZ | uguaaacauccccgacuggaag | ||||
hsa-miR-30bSZ | UGUAAACAUCCUACACUCAGCU | ||||
hsa-miR-30e-5p | UGUAAACAUCCUUGACUGGA | ||||
miR-384 | 791 | 797 | 1A | hsa-miR-384 | AUUCCUAGAAAUUGUUCAUA |
miR-409-5p | 2539 | 2545 | m8 | hsa-miR-409-5p | AGGUUACCCGAGCAACUUUGCA |
miR-9 | 586 | 592 | m8 | hsa-miR-9SZ | UCUUUGGUUAUCUAGCUGUAUGA |
miR-93.hd/291-3p/294/295/302/372/373/520 | 2108 | 2114 | m8 | hsa-miR-93brain | AAAGUGCUGUUCGUGCAGGUAG |
hsa-miR-302a | UAAGUGCUUCCAUGUUUUGGUGA | ||||
hsa-miR-302b | UAAGUGCUUCCAUGUUUUAGUAG | ||||
hsa-miR-302c | uaagugcuuccauguucagugg | ||||
hsa-miR-302d | UAAGUGCUUCCAUGUUUGAGUGU | ||||
hsa-miR-372 | AAAGUGCUGCGACAUUUGAGCGU | ||||
hsa-miR-373 | GAAGUGCUUCGAUUUUGGGGUGU | ||||
hsa-miR-520e | Aaagugcuuuuuugaggg | ||||
hsa-miR-520a | AAAGUGCUUCCCUUUGGACUGU | ||||
hsa-miR-520b | AAAGUGCUUCCUUUUAGAGGG | ||||
hsa-miR-520c | AAAGUGCUUCCUUUUAGAGGGUU | ||||
hsa-miR-520d | AAAGUGCUUCUCUUUGGUGGGUU |